This document discusses the management of pediatric status epilepticus. It defines status epilepticus as continuous seizure activity lasting more than 30 minutes or two or more sequential seizures without recovery of consciousness. Management involves early treatment with benzodiazepines like midazolam or lorazepam. If seizures continue, second-line treatments including fosphenytoin, phenytoin, valproate, or phenobarbital are used. Refractory status epilepticus is defined as continuous seizures lasting over 60 minutes despite initial treatment. It requires intensive care management including anesthetic agents like propofol to induce burst suppression on EEG.
Febrile seizure / Pediatrics
Simple vs. Complex seizure
Possible explanation of febrile seizure
Risk Factors for Febrile Seizures
Risk Factors for Recurrence of Febrile Seizure
Risk Factors for Occurrence of Subsequent Epilepsy After a Febrile Seizure
Genetic Factors
Evaluation
Lumbar Puncture
Optional LP
Electroencephalogram
Blood Studies
Neuroimaging
TREATMENT
Febrile seizure / Pediatrics
Simple vs. Complex seizure
Possible explanation of febrile seizure
Risk Factors for Febrile Seizures
Risk Factors for Recurrence of Febrile Seizure
Risk Factors for Occurrence of Subsequent Epilepsy After a Febrile Seizure
Genetic Factors
Evaluation
Lumbar Puncture
Optional LP
Electroencephalogram
Blood Studies
Neuroimaging
TREATMENT
This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
This slides contains all you need to know about "Status Epilepticus" in a nutshell. It includes definition, investigation, emergency management of status epilepticus. This educational material is suitable for med students, paramedics, nurses & neurology residents.
A review of literature about Stiripentol and Rufinamide and their role in Dravets and Lennox Gastaut Syndrome respectively. It also looks at off label indications of these two orphan drugs.
Management of Refractory, Super refractory SE and.pptxsumeetsingh837653
diagnosis and treatment of refractory and super refractory status epilepticus and NORSE
treatment guidelines of status epilepticus
dosages of various antiepileptic used in management of status epilepticus
Epilepsy Management: Key issues and challengesPramod Krishnan
This brief presentation summarises the key issues and challenges in Epilepsy management, including diagnosis, treatment, compliance, special populations, adverse effects, psychiatric comorbidities and ASM withdrawal.
This presentation focusses on the importance of diagnostic biomarkers for Alzheimer's disease. MRI, amyloid PET and CSF biomarkers are discussed in detail.
This presentation looks at the benign or non-epileptiform variants in EEG, their characteristics and identification. Examples of the common benign variants are provided in the presentation.
This presentation reviews the common artifacts in EEG, their identification and rectification. Examples of various artifacts are provided in the presentation.
This is a brief review of autoimmune epilepsies, especially autoimmune encephalitis, SREAT, NORSE, FIRES and Rasmussen's encephalitis. A brief overview of investigations and treatment is included.
This presentation looks at the role of Pregabalin in refractory trigeminal neuralgia and chemotherapy induced peripheral neuropathy through illustrative case studies.
This review focusses on the role of role of gut microbiota in health and disease, specifically multiple sclerosis. It looks at the interaction of gut microbiota, enteric nervous system, central nervous system, neuroendocrine system in the pathogenesis of multiple sclerosis
This presentation summarises the importance of genetics in epilepsy, whom to test, and the various tests available. It looks at the role of genetics in various forms of epilepsy and recent advances in precision medicine.
EEG in convulsive and non convulsive seizures in the intensive care unitPramod Krishnan
Case based discussion regarding the utility of EEG in the management of convulsive and non convulsive seizures, including status epilepticus in the intensive care unit
A review of epilepsy in the elderly, the etiopathogenesis, clinical challenges, diagnosis, use of antiseizure drugs and outcomes. Also the various special considerations in managing elderly patients with epilepsy.
A review of the common antiseizure drugs with broad spectrum action. We look at the major evidence in favour of valproate, topiramate, perampanel and brivaracetam.
Treatment of epilepsy polytherapy vs monotherapyPramod Krishnan
This presentation reviews the evidence regarding use of early polytherapy in patients with epilepsy with regards to seizure control and adverse effects. The advantages and disadvantages of polytherapy compared to monotherapy is addressed.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. DEFINITION
• “more than 30 minutes of a continuous seizure or
two or more sequential seizures without full
recovery of consciousness’
Working Group on Status Epilepticus of the Epilepsy Foundation of America.
• In clinical practice, a single seizure of >5 min (in
adults and children > 5 years of age) should be
considered as status epilepticus.
Lowenstein DH et al. NEJM 1998; 338: 970-6.
3. RATIONALE
• Increased risk of neuronal injury after 30 min when
homeostatic mechanism fail.
• A typical CPS/ GTCS in children lasts 62 sec (16- 108
sec) followed by upto 4 minutes of post ictal phase.
Theodore WH, et al. Neurology 1994; 44: 1403-07.
• If a seizure lasts >5 min, it tends to be prolonged.
• Response to treatment is better when commenced
early.
Mayer SA, et al. Arch Neurol 2002; 59: 205- 210.
4. EPIDEMIOLOGY
• North London Status Epilepticus Childhood
Surveillance Study (NLSTEPSS).
• Community based prospective study.
• Incidence: 17- 23/100,000.
Chin RF, et al. Lancet 2006; 368: 222- 229.
• In children, SE occurs within 2 years of the onset of
epilepsy.
• Recurrent SE is usually associated with underlying
neurologic disorder.
Sillanpaa M, et al. Ann Neurol 2002; 52: 303- 310.
5. EPIDEMIOLOGY
• Incidence in children < 5 years of age was
7.5/100,000.
• SE is most common in those < 2 years of age.
Shinnar S, et al. Epilepsia 1997; 38: 907-14.
• 25% of patients with SE have pre-existing epilepsy.
• 4-16% of patients with epilepsy have atleast 1
episode of SE.
• SE is the presenting symptoms in upto 1/3 rd of
such patients.
Hauser WA, et al. Neurology 1990; 40: 9-13.
7. ETIOLOGY
• SE is not a disease in itself but rather a
manifestation of a primary CNS insult or a systemic
disorder with secondary CNS effects.
• Cause may be acute or remote or part of a genetic
epileptic encephalopathy.
• It is important to identify and specifically treat the
precipitating cause, thus preventing ongoing
neurologic injury and seizure recurrence.
8. North London Status Epilepticus in Childhood Surveillance Study
Group Incidence
Acute symptomatic SE < 1 year: 16 %
1- 4 years: 2.5 %
5-15 years: 0.1 %
Acute on remote < 1 year: 6 %
1- 4 years: 5.3 %
5- 15 years: 0.7 %
Prolonged febrile seizure 4.1/ 100,000
Acute symptomatic SE 2.2/ 100,000
Remote symptomatic 2.3/ 100,000
Acute on remote 2.1/ 100,000
Idiopathic 1.4/ 100,000
Cryptogenic 0.2/ 100,000
Unclassified 1/ 100,000
9. Etiology in Children and Adults (Richmond Study)
Etiology % of children
(<16 years)
% of adults
(> 16 years)
Cerebrovascular 3.3 25.2
Medication change 19.8 18.9
Anoxia 5.3 10.7
Substance abuse 2.4 12.2
Metabolic 8.2 8.8
Unknown 9.3 8.1
Fever/ infection 35.7 4.6
Trauma 3.5 4.6
Tumor 0.7 4.3
CNS infection 4.8 1.8
Congenital 7.0 0.8
11. MECHANISMS
• SE occurs when factors that normally terminate
seizures fail.
• There is decreased cerebral inhibition, excessive
excitation or both.
• Altered receptor trafficking causing reduced
expression of GABA-a receptor and increased
expression of amino acid receptors play a role.
• Excessive excitation can cause neuronal injury.
12. blood flow
glucose conc in brain
glucose metabolism
oxygen supply to
brain
cardiac output.
catecholamine output
Stage of decompensation
(seizures > 30 min)
Failure of cerebral
autoregulation
Hypoxia, hypoglycemia
Acidosis,
dyselectrolytemia
DIC, Leucocytosis
Falling BP, Falling CO
Stage of compensation
(seizures < 30 min)
14. Classification of SE
Generalised
Partial
Aura status
Autonomic
status
Dyscognitive
status
Motor status
Special
status
Simple
motor
Complex
motor
Generalised
NCSE
(13%)
Convulsive
status
Focal Motor
status (10%)
Generalised
convulsive
status (77%)
15. Clinical stages of Status epilepticus
Stage Duration
Premonitory Confusion, myoclonus, increasing
seizure frequency
Incipient 0-5 min
Early 5- 30 min
Established 30 -60 min
Refractory > 60 min
Super refractory > 24 hrs
Post ictal
16. EEG progression of status epilepticus
Discrete seizures with
inter-ictal slowing
Waxing and waning of
inter- ictal discharges
Continuous ictal
discharges
Continuous ictal discharges
punctuated by flat periods
PED on a flat background
Lateralised Bilateral
20. RAMPART trial (Rapid Anticonvulsant
Medication Prior to Arrival Trial)
IM Midazolam 10
mg + IV placebo
IV Lorazepam 4
mg + IM placebo
Termination of clinical seizures prior to arrival
to ER. Need for a second rescue medication.
73.4% 63.4%
Not statistically significant. No difference in
seizure recurrence or adverse effects
22. Midazolam vs Diazepam
Study Type N Conclusion
McIntyre
et al 2005
Buccal Midazolam
(0.5 mg/kg) vs
Rectal Diazepam
(0.5 mg/kg)
177 56% of Midazolam group
had seizure control
compared to 27% for
diazepam.
Mpimbaza
et al 2008
Buccal Midazolam
Vs rectal
Diazepam.
330 Midazolam was
as well tolerated and more
effective than diazepam.
24. Initial management
in hospital
• Initial AEDs
• Maintenance
AEDs
• Treat:
Hypothermia
Hypotension
Thiamine
Investigations:
ABGA
Electrolytes
CBC
AED levels
ECG
Airway protection.
Oxygen.
IV line and IVF (NS).
Intubation +/-
Further etiological
work up.
Correction of metabolic
causes and specific
treatment.Transfer to ICU or
high dependency
25. NEUROIMAGING
• All new onset SE require CT/ MRI.
• FEBSTAT study: MRI was done within 72 hours of
presentation: 9% had T2 signal changes involving
hippocampus; another 2.5% had equivocal findings.
• Majority of children showed Hippocampal volume
loss a year later.
• NLSTEPSS: 20- 30% of children showed similar
findings 1 month after an SE.
26. EEG
• Unexplained altered sensorium.
• Use of neuromuscular paralysis.
• Refractory SE
• Control of overt seizures but sensorium is poor.
• NCSE occurs in 26% of children in whom GCSE has
been controlled with treatment.
• In children with one episode of GCSE, 1/3 rd had
EEG seizures on continuous EEG monitoring.
27. Stage 1: Early GCSE
Midazolam:
im or rectal: 5–10 mg
iv bolus: 0.1–0.3 mg/kg at < 4 mg/min
Buccal: 10 mg.
Lorazepam:
iv push: 0.1 mg/kg (<2 mg/min)
Diazepam:
IV: 0.15 mg/kg, at < 5 mg/min
Rectal: 10–30 mg
Repeat once if seizures
continue beyond 5-10
min and RR> 8/min.
28. Veterans Affairs Cooperative Trial
N= 384 GCSE
Inj Phenobarbital
15 mg/kg
Inj Phenytoin
18 mg/kg
Inj Diazepam
0.15 mg/kg +
Inj Phenytoin 18 mg/kg
Inj Lorazepam
0.1 mg/kg
64.9% 43.6% 58.2% 55.8%
Clinical and EEG termination of seizures.
No difference in recurrence rates between the 4 groups.
Treiman DM et al. NEJM 1998; 339: 792-8
29. Lorazepam Vs Diazepam
Lorazepam Diazepam
Longer duration of action
(>6 hrs).
Shorter duration (20 min) due
to rapid redistribution.
Onset of action upto 5 min. 1 min.
Risk of respiratory depression
is less.
Risk is more.
Light proof storage. Not required.
Refrigeration is recommended. Not required.
30. IYJ, 54 yrs/ M, with epilepsy, on Phenobarbitone, had a seizure
during EEG with loss of consciousness. CT brain showed multiple
NCC.
40. Phenytoin Vs Fosphenytoin
Fosphenytoin Phenytoin
Can be given IV or IM. Cannot be given IM.
Less cardiac toxicity. More cardiac adverse effects.
Dextrose containing fluids can
be used.
Cannot be used.
Can be infused at a faster rate. Slower infusion
Phenytoin/ Fosphenytoin are favoured over Phenobarbital
inspite of comparable efficacy in view of better safety profile.
43. DEFINITION
• Continuous or repetitive seizures lasting more than
60 minutes despite treatment with a
benzodiazepine and another standard
anticonvulsant
Shorvon S. Status Epilepticus. Cambridge University Press, 1994: p201.
• 9-31% of patients with GCSE evolve into RSE.
• Morbidity and mortality are greater.
44. NORSE SYNDROME
New onset refractory status epilepticus (NORSE)
• Patients who develop refractory status epilepticus
with no prior history of epilepsy, or identifiable
causative factors.
45. RSE
Intubate,
ventilate, ICU care
Investigate cause, and
specific therapy
Hydration, and
supportive care
One of Inj Vaproate/ Phenobarbital/
Levetiracetam
Inj Lacosamide or
Oral Topiramate
Anesthetic
agents
One of VPA/ PB/
LEV
46. Continuous EEG
monitoring
Seizures aborted but
sensorium remains poor,
suspicion of NCSE.
EEG end points:
Burst suppression
pattern.
Suppression of
electrographic seizures.
Taper anesthetic
agents every 3 hrs
Maintain burst
suppression for 12
hours, interburst
interval of 10 sec
Seizure
Recurrence
Restart
same agent
47. 23 yrs/ M, epilepsy patient with normal MRI brain on phenytoin
presented with status epilepticus following drug default. Clinical
seizures subsided after Lorazepam and Phenytoin injection.
48. Sensorium did not improve. EEG showed electrographic seizures of
left fronto-temporal origin in the form of evolving rhythmic spike
and wave discharge with rapid generalisation.
49. Each seizure lasted 2-4 minutes followed by diffuse slowing. 15- 20
seizures were recorded over the next one hour.
50. Facial twitching on the right side and eye deviation to the right
were the only clinical features. HR and BP changes were noted.
51. Inj Valproate 1.5 gm was administered, but was ineffective. Inj
Propofol was started.
52.
53. On starting propofol, seizures terminated in 8 minutes. This was
followed by diffuse slowing, more on the left side. Motor
manifestations stopped.
54. Burst suppression pattern was obtained, initially with short inter
burst interval of 1-2 seconds. Propofol infusion was titrated till this
pattern was obtained.
55. Inj Phenytoin and Valproate were continued. No etiology other
than AED default was noted on evaluation.
56. Burst suppression pattern was sustained with interburst interval of
3– 5 seconds. This was maintained for more than 10 hours.
57.
58. Long inter burst interval of 7-8 seconds was obtained. Inj
Levetiracetam was started prior to propofol withdrawal.
59. ANESTHETIC AGENTS
Features Propofol Midazolam Pentobarbitone
Loading dose 3-5 mg/kg,
upto 10 mg/kg
0.2 mg/kg, with
0.2-0.4 mg/kg
increments every 5
min till seizures
stop or a max dose
of 2.9 mg/kg is
reached.
5 mg/kg, with 5
mg/kg increments
till seizures stop.
Max bolus rate is
25-50 mg/min.
Maintenance 30-100 ug/kg/min 0.1-0.2 mg/kg/hr. 0.5-10 mg/kg/hr.
Breakthrough
seizures
Additional 1-3
mg/kg
Additional bolus
and 20% increase
in maintenance
infusion
60. ANESTHETIC AGENTS
Propofol Midazolam
Rapid onset and offset of action-
no accumulation.
Rapid onset, but slow offset due
to accumulation.
Highly lipophilic Water soluble
No dose reduction required in
hepatic or renal disease
Metabolised by liver, excreted by
kidney.
Lower doses with concomitant
BZD use
Propofol sparing effect.
No accumulation noted. Accumulation observed.
Multiple MOA GABA-A receptor
Propofol infusion syndrome. Tachyphylaxis
Risk of acidosis with ZSN, TPM Longer time to awakening.
61. AZU, 55 yrs/ M, with left transverse sinus thrombosis with left
fronto- parietal hemorrhagic infarct and status epilepticus.
62. EEG shows seizure evolution over the left hemispheric region.
Right facial jerking and right sided stiffening and head deviation
was noted.
63. Inj Lorazepam was followed by Inj Fosphenytoin, and later Inj
Midazolam, followed by intubation and transfer to MICU.
64. Inj Valproate 1.5 gm was added, followed by Inj Levetiracetam.
Seizures continued. Inj Propofol infusion was started.
65. Recurrent seizures continued for 6 hours. During this time Inj
Midazolam was added. Metabolic abnormalities were corrected.
Anticoagulation and Anti-edema measures were continued.
66. Seizures subsided and long interburst interval of 9-10 seconds were
obtained. Maintained on PHT, LEV and VPA. VPA and later PHT was
withdrawn during follow- up.
67. Early use of Anesthetic Agents
Disease condition
Post-operative patients, especially cardiac and neurosurgery.
Raised ICP, brain tumor, trauma, hematoma, SAH
Stroke
CNS infections
Hepatic or multi-organ failure
Hyperthermia, hyperthyroidism.
Metabolic disorders prone to raised ICP, DKA, organic acid
disorders.
69. DEFINITION
• Status epilepticus that continues or recurs 24 h or
more after the onset of anaesthetic therapy, or
recurs on the reduction or withdrawal of
anaesthesia.
• 15% of all the cases with status epilepticus
admitted to hospital will become super-refractory.
70. JK, 31 yrs/ M, with short history of fever, followed by altered
sensorium and 2-3 episodes of GTCS. Had seizures at arrival and
was given Inj Lorazepam followed by Inj Phenytoin.
71. Sensorium did not improve. Shifted to MICU. Intubated. MRI brain
was normal. CSF showed mild lymphocytic pleocytosis. EEG
showed right hemispheric seizures.
72. Had few more clinical seizures. EEG showed evolving right fronto-
temporal rhythmic spikes with spread to the opposite side.
73. Each seizures lasted 4-8 minutes. In view of mild deranged LFTs, he
was started on Inj Levetiracetam 1.5 gm infusion. Seizure duration
subsided and frequency reduced. HSV PCR was negative.
74. Inj Propofol was started. But seizures continued. Inj Midazolam
was started. Frequent seizures continued for almost 2 days. Inj
Lacosamide 200 mg BD was added. AED levels were adequate.
77. A definite burst suppression could not be obtained. Diffuse slowing
was noted. Brief seizures occurred during Midazolam withdrawal.
Sensorium improved after 4-5 days.
80. Common reasons for treatment failure
• Inadequate drug treatment
• Failure to initiate or continue maintenance
antiepileptic drug therapy.
• Medical factors can exacerbate seizures.
• Failure to treat (or identify) the underlying cause
• Misdiagnosis- pseudostatus epilepticus.
81. GCSE in special situations
Patient group Treatment
Wilson Disease,
INH toxicity
Pyridoxine supplementation at 25
mg/day (Penicillamine dependent
pyridoxine deficiency).
Porphyrias Use non enzyme inducing AEDs like
LEV. Mg, Lorazepam can be used.
Coexisting liver disease Avoid VPA. LEV is best.
Hepatic encephalopathy AEDs are largely ineffective.
82. PROGNOSIS
• Mortality rate: 3- 11 %
• Related to age, etiology, acute/ progressive
symptomatic causes.
• Richmond Study: highest mortality was noted in the
first 6 months of life, followed by the next 6
months.
DeLorenzo RJ, et al. Neurology 1996; 46: 1029-1035.
• 34% of children with SE duration of > 30 min
developed neuro developmental deterioration.
Barnard C, et al. J Child Neurol 1999; 14: 787- 794.
Netherlands study. In NCSe patients 40 had complex partial SE and 25 had absence SE.
Response to treatment depends on the EEG stage. Discrete seizures were all controlled with diazepam. In the PED stage, only 20 % or less patients were controlled with treatment.